These results are important, as non-human primates model liver disease pathology better than rodents, which are less likely to develop ALD [86]
Treatment with GLP-1 mimetics improves hepatic insulin signaling in NAFLD animal models, and these effects could be invoked by direct stimulation of hepatic GLP-1 receptor
Arrows added in purple to show the direction of gene changes for key enzymes involved in this pathway following melatonin treatment
Because of this, predicting the consequences of neuropeptide release and/or activation can be difficult
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) effectively manage type 2 diabetes and promote weight loss, but their gastrointestinal effectsincluding nausea, vomiting, and diarrheacan disrupt fluid and electrolyte balance